nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromazepam—GABRQ—attention deficit hyperactivity disorder	0.799	1	CbGaD
Bromazepam—GABRQ—forebrain—attention deficit hyperactivity disorder	0.00233	0.0334	CbGeAlD
Bromazepam—GABRR1—forebrain—attention deficit hyperactivity disorder	0.00194	0.0279	CbGeAlD
Bromazepam—Nitrazepam—GABRQ—attention deficit hyperactivity disorder	0.00173	0.389	CrCbGaD
Bromazepam—GABRD—forebrain—attention deficit hyperactivity disorder	0.00169	0.0242	CbGeAlD
Bromazepam—GABRG1—forebrain—attention deficit hyperactivity disorder	0.00162	0.0233	CbGeAlD
Bromazepam—GABRA5—forebrain—attention deficit hyperactivity disorder	0.00157	0.0225	CbGeAlD
Bromazepam—Oxazepam—GABRQ—attention deficit hyperactivity disorder	0.00149	0.335	CrCbGaD
Bromazepam—GABRA4—forebrain—attention deficit hyperactivity disorder	0.00142	0.0204	CbGeAlD
Bromazepam—GABRQ—nervous system—attention deficit hyperactivity disorder	0.00126	0.0181	CbGeAlD
Bromazepam—GABRR3—nervous system—attention deficit hyperactivity disorder	0.00126	0.0181	CbGeAlD
Bromazepam—Diazepam—GABRQ—attention deficit hyperactivity disorder	0.00122	0.275	CrCbGaD
Bromazepam—GABRQ—central nervous system—attention deficit hyperactivity disorder	0.00122	0.0175	CbGeAlD
Bromazepam—GABRB2—forebrain—attention deficit hyperactivity disorder	0.00119	0.0171	CbGeAlD
Bromazepam—GABRG2—forebrain—attention deficit hyperactivity disorder	0.00119	0.0171	CbGeAlD
Bromazepam—GABRD—midbrain—attention deficit hyperactivity disorder	0.00111	0.016	CbGeAlD
Bromazepam—GABRG3—nervous system—attention deficit hyperactivity disorder	0.00111	0.0159	CbGeAlD
Bromazepam—GABRR2—nervous system—attention deficit hyperactivity disorder	0.0011	0.0157	CbGeAlD
Bromazepam—GABRA2—forebrain—attention deficit hyperactivity disorder	0.00109	0.0156	CbGeAlD
Bromazepam—GABRG1—midbrain—attention deficit hyperactivity disorder	0.00107	0.0154	CbGeAlD
Bromazepam—GABRG3—central nervous system—attention deficit hyperactivity disorder	0.00107	0.0153	CbGeAlD
Bromazepam—GABRR1—nervous system—attention deficit hyperactivity disorder	0.00105	0.0151	CbGeAlD
Bromazepam—GABRA1—forebrain—attention deficit hyperactivity disorder	0.00105	0.0151	CbGeAlD
Bromazepam—GABRB1—midbrain—attention deficit hyperactivity disorder	0.00104	0.0149	CbGeAlD
Bromazepam—GABRR2—cerebellum—attention deficit hyperactivity disorder	0.00103	0.0148	CbGeAlD
Bromazepam—GABRR1—central nervous system—attention deficit hyperactivity disorder	0.00101	0.0146	CbGeAlD
Bromazepam—GABRQ—brain—attention deficit hyperactivity disorder	0.000965	0.0139	CbGeAlD
Bromazepam—GABRD—nervous system—attention deficit hyperactivity disorder	0.000916	0.0132	CbGeAlD
Bromazepam—GABRB3—forebrain—attention deficit hyperactivity disorder	0.000913	0.0131	CbGeAlD
Bromazepam—GABRD—central nervous system—attention deficit hyperactivity disorder	0.000882	0.0127	CbGeAlD
Bromazepam—GABRG1—nervous system—attention deficit hyperactivity disorder	0.000882	0.0127	CbGeAlD
Bromazepam—GABRA6—nervous system—attention deficit hyperactivity disorder	0.000877	0.0126	CbGeAlD
Bromazepam—GABRD—cerebellum—attention deficit hyperactivity disorder	0.000862	0.0124	CbGeAlD
Bromazepam—GABRB1—nervous system—attention deficit hyperactivity disorder	0.000855	0.0123	CbGeAlD
Bromazepam—GABRA5—nervous system—attention deficit hyperactivity disorder	0.00085	0.0122	CbGeAlD
Bromazepam—GABRG1—central nervous system—attention deficit hyperactivity disorder	0.000849	0.0122	CbGeAlD
Bromazepam—GABRG3—brain—attention deficit hyperactivity disorder	0.000846	0.0121	CbGeAlD
Bromazepam—GABRA6—central nervous system—attention deficit hyperactivity disorder	0.000844	0.0121	CbGeAlD
Bromazepam—GABRG1—cerebellum—attention deficit hyperactivity disorder	0.00083	0.0119	CbGeAlD
Bromazepam—GABRA6—cerebellum—attention deficit hyperactivity disorder	0.000825	0.0119	CbGeAlD
Bromazepam—GABRB1—central nervous system—attention deficit hyperactivity disorder	0.000823	0.0118	CbGeAlD
Bromazepam—GABRA5—central nervous system—attention deficit hyperactivity disorder	0.000819	0.0118	CbGeAlD
Bromazepam—GABRR1—brain—attention deficit hyperactivity disorder	0.000806	0.0116	CbGeAlD
Bromazepam—GABRB1—cerebellum—attention deficit hyperactivity disorder	0.000805	0.0116	CbGeAlD
Bromazepam—GABRA3—nervous system—attention deficit hyperactivity disorder	0.000792	0.0114	CbGeAlD
Bromazepam—GABRG2—midbrain—attention deficit hyperactivity disorder	0.000785	0.0113	CbGeAlD
Bromazepam—GABRB2—midbrain—attention deficit hyperactivity disorder	0.000785	0.0113	CbGeAlD
Bromazepam—GABRA4—nervous system—attention deficit hyperactivity disorder	0.000772	0.0111	CbGeAlD
Bromazepam—GABRA3—central nervous system—attention deficit hyperactivity disorder	0.000762	0.0109	CbGeAlD
Bromazepam—GABRA4—central nervous system—attention deficit hyperactivity disorder	0.000743	0.0107	CbGeAlD
Bromazepam—GABRA4—cerebellum—attention deficit hyperactivity disorder	0.000726	0.0104	CbGeAlD
Bromazepam—GABRD—brain—attention deficit hyperactivity disorder	0.0007	0.0101	CbGeAlD
Bromazepam—GABRA1—midbrain—attention deficit hyperactivity disorder	0.000693	0.00996	CbGeAlD
Bromazepam—GABRG1—brain—attention deficit hyperactivity disorder	0.000674	0.00968	CbGeAlD
Bromazepam—GABRA6—brain—attention deficit hyperactivity disorder	0.00067	0.00963	CbGeAlD
Bromazepam—GABRB1—brain—attention deficit hyperactivity disorder	0.000654	0.00939	CbGeAlD
Bromazepam—GABRA5—brain—attention deficit hyperactivity disorder	0.00065	0.00934	CbGeAlD
Bromazepam—GABRG2—nervous system—attention deficit hyperactivity disorder	0.000645	0.00927	CbGeAlD
Bromazepam—GABRB2—nervous system—attention deficit hyperactivity disorder	0.000645	0.00927	CbGeAlD
Bromazepam—GABRB2—central nervous system—attention deficit hyperactivity disorder	0.000621	0.00893	CbGeAlD
Bromazepam—GABRG2—central nervous system—attention deficit hyperactivity disorder	0.000621	0.00893	CbGeAlD
Bromazepam—GABRB2—cerebellum—attention deficit hyperactivity disorder	0.000607	0.00872	CbGeAlD
Bromazepam—GABRG2—cerebellum—attention deficit hyperactivity disorder	0.000607	0.00872	CbGeAlD
Bromazepam—GABRA3—brain—attention deficit hyperactivity disorder	0.000605	0.00869	CbGeAlD
Bromazepam—GABRB3—midbrain—attention deficit hyperactivity disorder	0.000603	0.00866	CbGeAlD
Bromazepam—GABRA4—brain—attention deficit hyperactivity disorder	0.00059	0.00847	CbGeAlD
Bromazepam—GABRA2—nervous system—attention deficit hyperactivity disorder	0.00059	0.00847	CbGeAlD
Bromazepam—GABRE—nervous system—attention deficit hyperactivity disorder	0.000585	0.0084	CbGeAlD
Bromazepam—GABRA1—nervous system—attention deficit hyperactivity disorder	0.00057	0.00819	CbGeAlD
Bromazepam—GABRA2—central nervous system—attention deficit hyperactivity disorder	0.000568	0.00815	CbGeAlD
Bromazepam—GABRE—central nervous system—attention deficit hyperactivity disorder	0.000563	0.00809	CbGeAlD
Bromazepam—GABRA2—cerebellum—attention deficit hyperactivity disorder	0.000555	0.00797	CbGeAlD
Bromazepam—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.000549	0.00788	CbGeAlD
Bromazepam—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.000536	0.0077	CbGeAlD
Bromazepam—GABRB3—nervous system—attention deficit hyperactivity disorder	0.000496	0.00712	CbGeAlD
Bromazepam—GABRB2—brain—attention deficit hyperactivity disorder	0.000493	0.00709	CbGeAlD
Bromazepam—GABRG2—brain—attention deficit hyperactivity disorder	0.000493	0.00709	CbGeAlD
Bromazepam—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.000491	0.00706	CbGeAlD
Bromazepam—GABRB3—central nervous system—attention deficit hyperactivity disorder	0.000477	0.00685	CbGeAlD
Bromazepam—GABRB3—cerebellum—attention deficit hyperactivity disorder	0.000466	0.0067	CbGeAlD
Bromazepam—GABRA2—brain—attention deficit hyperactivity disorder	0.000451	0.00647	CbGeAlD
Bromazepam—GABRE—brain—attention deficit hyperactivity disorder	0.000447	0.00642	CbGeAlD
Bromazepam—GABRA1—brain—attention deficit hyperactivity disorder	0.000436	0.00626	CbGeAlD
Bromazepam—GABRB3—brain—attention deficit hyperactivity disorder	0.000379	0.00544	CbGeAlD
Bromazepam—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.000315	0.00453	CbGeAlD
Bromazepam—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.000304	0.00436	CbGeAlD
Bromazepam—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.000297	0.00426	CbGeAlD
Bromazepam—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000254	0.00364	CbGeAlD
Bromazepam—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000244	0.00351	CbGeAlD
Bromazepam—CYP2E1—brain—attention deficit hyperactivity disorder	0.000241	0.00346	CbGeAlD
Bromazepam—GABRA5—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.00016	0.00126	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000158	0.00124	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000158	0.00124	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000157	0.00124	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000157	0.00123	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000157	0.00123	CbGpPWpGaD
Bromazepam—GABRG3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000157	0.00123	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000156	0.00122	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000155	0.00122	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000155	0.00122	CbGpPWpGaD
Bromazepam—GABRB1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000155	0.00122	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000154	0.00121	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000154	0.00121	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000153	0.0012	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000152	0.0012	CbGpPWpGaD
Bromazepam—GABRR1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000151	0.00119	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000151	0.00119	CbGpPWpGaD
Bromazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—attention deficit hyperactivity disorder	0.000151	0.00119	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00015	0.00118	CbGpPWpGaD
Bromazepam—GABRR1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00015	0.00118	CbGpPWpGaD
Bromazepam—CYP1A2—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.000149	0.00117	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000148	0.00116	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000147	0.00116	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000146	0.00115	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000146	0.00115	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000146	0.00115	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000145	0.00114	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000144	0.00114	CbGpPWpGaD
Bromazepam—GABRR2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000144	0.00114	CbGpPWpGaD
Bromazepam—GABRQ—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000144	0.00114	CbGpPWpGaD
Bromazepam—GABRR2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000143	0.00113	CbGpPWpGaD
Bromazepam—GABRQ—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000143	0.00113	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000142	0.00112	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00014	0.0011	CbGpPWpGaD
Bromazepam—GABRG3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00014	0.0011	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000139	0.0011	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000139	0.00109	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000138	0.00109	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000138	0.00109	CbGpPWpGaD
Bromazepam—GABRB1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000138	0.00108	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000136	0.00107	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000135	0.00107	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000135	0.00106	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000133	0.00105	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000133	0.00105	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000133	0.00105	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000132	0.00104	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000132	0.00104	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000132	0.00104	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000131	0.00103	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00013	0.00102	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00013	0.00102	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.00013	0.00102	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.00013	0.00102	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.00013	0.00102	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000129	0.00102	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000129	0.00102	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000129	0.00101	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—attention deficit hyperactivity disorder	0.000129	0.00101	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000129	0.00101	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000128	0.00101	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000127	0.001	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000127	0.001	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000127	0.000997	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000127	0.000995	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000126	0.000991	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000125	0.00098	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000124	0.000974	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000124	0.000974	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000123	0.000967	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000123	0.000967	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000122	0.000956	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000121	0.00095	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000121	0.000949	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.00012	0.000948	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.00012	0.000945	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000119	0.000936	CbGpPWpGaD
Bromazepam—GABRG3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000119	0.000935	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000119	0.000933	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000118	0.000931	CbGpPWpGaD
Bromazepam—GABRG3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000118	0.000928	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000118	0.000927	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000118	0.000926	CbGpPWpGaD
Bromazepam—GABRB1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000117	0.000921	CbGpPWpGaD
Bromazepam—GABRB1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000116	0.000914	CbGpPWpGaD
Bromazepam—GABRB3—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.000116	0.000913	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000116	0.000912	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000116	0.00091	CbGpPWpGaD
Bromazepam—GABRR1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000115	0.000905	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000114	0.000899	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000114	0.000893	CbGpPWpGaD
Bromazepam—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000112	0.000884	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000112	0.000883	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000112	0.000881	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000111	0.000876	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000111	0.000871	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000111	0.00087	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000111	0.00087	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000111	0.00087	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00011	0.000868	CbGpPWpGaD
Bromazepam—GABRA6—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00011	0.000865	CbGpPWpGaD
Bromazepam—GABRR2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00011	0.000864	CbGpPWpGaD
Bromazepam—GABRQ—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.00011	0.000864	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00011	0.000862	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000109	0.00086	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000109	0.000856	CbGpPWpGaD
Bromazepam—GABRA4—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000109	0.000854	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000108	0.000847	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000107	0.000842	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000106	0.000836	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000106	0.000831	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000106	0.00083	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.000106	0.00083	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000104	0.000816	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000102	0.000802	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000101	0.000797	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000101	0.000796	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000101	0.000796	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.0001	0.000787	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	9.98e-05	0.000785	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	9.95e-05	0.000783	CbGpPWpGaD
Bromazepam—GABRB2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	9.94e-05	0.000781	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	9.86e-05	0.000775	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.83e-05	0.000773	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.72e-05	0.000765	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	9.69e-05	0.000762	CbGpPWpGaD
Bromazepam—GABRA5—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	9.65e-05	0.000759	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.65e-05	0.000759	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.55e-05	0.000751	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.48e-05	0.000746	CbGpPWpGaD
Bromazepam—GABRA3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	9.48e-05	0.000745	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.42e-05	0.000741	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	9.41e-05	0.00074	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.38e-05	0.000738	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	9.35e-05	0.000735	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.32e-05	0.000733	CbGpPWpGaD
Bromazepam—GABRA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	9.31e-05	0.000733	CbGpPWpGaD
Bromazepam—GABRB3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	9.25e-05	0.000728	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.25e-05	0.000728	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.15e-05	0.00072	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—COMT—attention deficit hyperactivity disorder	9.11e-05	0.000716	CbGpPWpGaD
Bromazepam—GABRG2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	9.09e-05	0.000715	CbGpPWpGaD
Bromazepam—GABRG3—Neuronal System—MAOA—attention deficit hyperactivity disorder	9.04e-05	0.000711	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	9.02e-05	0.000709	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—COMT—attention deficit hyperactivity disorder	8.97e-05	0.000706	CbGpPWpGaD
Bromazepam—GABRB1—Neuronal System—MAOA—attention deficit hyperactivity disorder	8.91e-05	0.000701	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.76e-05	0.000689	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	8.7e-05	0.000684	CbGpPWpGaD
Bromazepam—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	8.67e-05	0.000682	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.6e-05	0.000677	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—COMT—attention deficit hyperactivity disorder	8.49e-05	0.000668	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.45e-05	0.000665	CbGpPWpGaD
Bromazepam—GABRA6—Neuronal System—MAOA—attention deficit hyperactivity disorder	8.43e-05	0.000663	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.4e-05	0.00066	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—COMT—attention deficit hyperactivity disorder	8.38e-05	0.000659	CbGpPWpGaD
Bromazepam—GABRA4—Neuronal System—MAOA—attention deficit hyperactivity disorder	8.32e-05	0.000655	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.25e-05	0.000649	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	8.09e-05	0.000636	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	8e-05	0.000629	CbGpPWpGaD
Bromazepam—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	7.94e-05	0.000625	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	7.9e-05	0.000621	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—COMT—attention deficit hyperactivity disorder	7.67e-05	0.000603	CbGpPWpGaD
Bromazepam—GABRB2—Neuronal System—MAOA—attention deficit hyperactivity disorder	7.61e-05	0.000599	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—COMT—attention deficit hyperactivity disorder	7.45e-05	0.000586	CbGpPWpGaD
Bromazepam—GABRA5—Neuronal System—MAOA—attention deficit hyperactivity disorder	7.4e-05	0.000582	CbGpPWpGaD
Bromazepam—GABRR1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	7.33e-05	0.000577	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—COMT—attention deficit hyperactivity disorder	7.31e-05	0.000575	CbGpPWpGaD
Bromazepam—GABRA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	7.26e-05	0.000571	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	7.21e-05	0.000567	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—COMT—attention deficit hyperactivity disorder	7.19e-05	0.000565	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—COMT—attention deficit hyperactivity disorder	7.14e-05	0.000562	CbGpPWpGaD
Bromazepam—GABRA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	7.14e-05	0.000561	CbGpPWpGaD
Bromazepam—GABRB3—Neuronal System—MAOA—attention deficit hyperactivity disorder	7.09e-05	0.000558	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—COMT—attention deficit hyperactivity disorder	7.01e-05	0.000551	CbGpPWpGaD
Bromazepam—GABRR2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.99e-05	0.00055	CbGpPWpGaD
Bromazepam—GABRQ—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.99e-05	0.00055	CbGpPWpGaD
Bromazepam—GABRG2—Neuronal System—MAOA—attention deficit hyperactivity disorder	6.96e-05	0.000548	CbGpPWpGaD
Bromazepam—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	6.76e-05	0.000531	CbGpPWpGaD
Bromazepam—CYP1A2—Phase II conjugation—COMT—attention deficit hyperactivity disorder	6.18e-05	0.000486	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	6.13e-05	0.000482	CbGpPWpGaD
Bromazepam—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	6.09e-05	0.000479	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	6.01e-05	0.000473	CbGpPWpGaD
Bromazepam—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.97e-05	0.000469	CbGpPWpGaD
Bromazepam—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.93e-05	0.000466	CbGpPWpGaD
Bromazepam—GABRG3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.76e-05	0.000453	CbGpPWpGaD
Bromazepam—GABRB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.67e-05	0.000446	CbGpPWpGaD
Bromazepam—GABRA6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.37e-05	0.000422	CbGpPWpGaD
Bromazepam—GABRA4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.3e-05	0.000417	CbGpPWpGaD
Bromazepam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	5.21e-05	0.00041	CbGpPWpGaD
Bromazepam—GABRB2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.85e-05	0.000381	CbGpPWpGaD
Bromazepam—GABRA5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.71e-05	0.00037	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—COMT—attention deficit hyperactivity disorder	4.64e-05	0.000365	CbGpPWpGaD
Bromazepam—GABRA3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.62e-05	0.000364	CbGpPWpGaD
Bromazepam—CYP2C19—Biological oxidations—MAOA—attention deficit hyperactivity disorder	4.61e-05	0.000362	CbGpPWpGaD
Bromazepam—CYP2C19—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	4.57e-05	0.00036	CbGpPWpGaD
Bromazepam—GABRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.55e-05	0.000357	CbGpPWpGaD
Bromazepam—GABRB3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.52e-05	0.000355	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—attention deficit hyperactivity disorder	4.45e-05	0.00035	CbGpPWpGaD
Bromazepam—CYP1A2—Aryl Hydrocarbon Receptor—EP300—attention deficit hyperactivity disorder	4.45e-05	0.00035	CbGpPWpGaD
Bromazepam—GABRG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.43e-05	0.000349	CbGpPWpGaD
Bromazepam—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.18e-05	0.000329	CbGpPWpGaD
Bromazepam—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.88e-05	0.000305	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	3.61e-05	0.000284	CbGpPWpGaD
Bromazepam—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	3.59e-05	0.000282	CbGpPWpGaD
Bromazepam—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	3.56e-05	0.00028	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	2.79e-05	0.000219	CbGpPWpGaD
Bromazepam—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	2.77e-05	0.000218	CbGpPWpGaD
Bromazepam—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	2.75e-05	0.000216	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.46e-05	0.000193	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.9e-05	0.000149	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.7e-05	0.000133	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.7e-05	0.000133	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.67e-05	0.000131	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.55e-05	0.000122	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.48e-05	0.000116	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.36e-05	0.000107	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—TPH2—attention deficit hyperactivity disorder	1.31e-05	0.000103	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.31e-05	0.000103	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.29e-05	0.000102	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—DPYD—attention deficit hyperactivity disorder	1.29e-05	0.000101	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.2e-05	9.42e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.14e-05	8.97e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.05e-05	8.23e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	1.03e-05	8.09e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.02e-05	8.03e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	1.02e-05	8.02e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.02e-05	8.02e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	1e-05	7.89e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.96e-06	7.84e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.33e-06	7.34e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.15e-06	6.41e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—COMT—attention deficit hyperactivity disorder	7.93e-06	6.24e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—MAOA—attention deficit hyperactivity disorder	7.88e-06	6.19e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.87e-06	6.19e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	7.87e-06	6.19e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	7.76e-06	6.11e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	7.74e-06	6.09e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.64e-06	6.01e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	7.2e-06	5.66e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.29e-06	4.95e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	6.18e-06	4.86e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	6.14e-06	4.83e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.99e-06	4.71e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	5.95e-06	4.68e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	4.77e-06	3.75e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	4.74e-06	3.72e-05	CbGpPWpGaD
Bromazepam—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	4.41e-06	3.47e-05	CbGpPWpGaD
Bromazepam—CYP2C19—Metabolism—EP300—attention deficit hyperactivity disorder	3.4e-06	2.68e-05	CbGpPWpGaD
Bromazepam—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	2.65e-06	2.08e-05	CbGpPWpGaD
Bromazepam—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	2.05e-06	1.61e-05	CbGpPWpGaD
